(262 days)
Dynamic Orthotic Cranioplasty (DOC)
K/DEN numbers are not provided in the text.
No
The 510(k) summary describes a custom-made thermoplastic orthosis for cranial reshaping and does not mention any AI or ML components, image processing, or data-driven algorithms.
Yes
The device is described as an "orthosis" intended to treat a medical condition (positional plagiocephaly) by applying pressure to reshape an infant's cranium, which aligns with the definition of a therapeutic device.
No
The device is described as an orthosis intended to apply pressure and provide realignment space to improve cranial symmetry and shape in infants with positional plagiocephaly, not to diagnose a condition.
No
The device description explicitly states it is a "custom made medical device" with a "thermoplastic construct" and a "semi-rigid outer shell" made of polypropylene and polyethylene, clearly indicating it is a physical hardware device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The Cranial Solutions Orthosis is a physical device applied externally to the infant's head. Its function is to apply pressure and provide space for cranial reshaping. It does not involve testing or analyzing biological samples.
- Intended Use: The intended use clearly describes a physical intervention for a structural condition (positional plagiocephaly), not a diagnostic test.
Therefore, the Cranial Solutions Orthosis falls under the category of a medical device, specifically an orthosis, rather than an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The Cranial Solutions Orthosis is intended for use on infants from three to eighteen months of age with moderate to severe non-synostotic positional plagiocephaly,including infants with plagiocephalic, brachycephalic, and scaphocephalic shaped heads. The CSO is intended to apply gentle pressure to prominent regions of the infant's cranium, and to provide realignment space for depressed cranial regions to improve cranial symmetry and or shape.
Product codes
MVA
Device Description
The CSO is a custom made medical device intended to apply gentle pressure to prominent regions of the infant's cranium, and to provide realignment space for depressed cranial regions to improve symmetry and or shape. The device is of thermoplastic construct. A semi-rigid outer shell of Orthopedic grade copolymer polypropylene thermobonded to a medium durometer polyethylene foam inner liner(Volara). The formula for the outer shell is [ch(ch3)ch2-] 90% polypropylene and 10% polyethylene. By design the CSO is a dynamic orthotic device. Both devices are of thermoplastic construction consisting of a semirigid outer shell bonded to a soft inner lining. Both outer shells are of Orthopedic grade plastic with hazard data all within OSHA permissible exposure limits with none know medical conditions aggravated by exposure. The CSO and DOC inner linings have been tested and approved by the FDA for long term skin contact. Both devices are of dynamic design , and when applied to an infant mild pressure, a low energy load , will constrain and correct abnormal growth . Normal growth will take place in the provided space and the cranial symmetry will be much improved. Standard treatment time for both cranial orthoses is three to four months. By design specifications and design intent the CSO is vacuum formed over a modified cranial model obtained from a plaster cast taken of the infant's calvarium . Both the cranial solutions orthosis and the predicate device are formed only after the cranial model has been corrected or restored to as near as complete symmetry as possible. This exact correction will produce a very accurate and effective fit.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Cranium, head
Indicated Patient Age Range
three to eighteen months of age
Intended User / Care Setting
Prescription Use (Part 21 CFR 801 Subpart D)
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Dynamic Orthotic Cranioplasty (DOC)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 882.5970 Cranial orthosis.
(a)
Identification. A cranial orthosis is a device that is intended for medical purposes to apply pressure to prominent regions of an infant's cranium in order to improve cranial symmetry and/or shape in infants from 3 to 18 months of age, with moderate to severe nonsynostotic positional plagiocephaly, including infants with plagiocephalic-, brachycephalic-, and scaphocephalic-shaped heads.(b)
Classification. Class II (special controls) (prescription use in accordance with § 801.109 of this chapter, biocompatibility testing, and labeling (contraindications, warnings, precautions, adverse events, instructions for physicians and parents)).
0
K063133 pg 1 of 4
JUL - 2 - 2 - 2007
Image /page/0/Picture/2 description: The image shows a black and white drawing of a human skull from a side view. The skull is detailed, showing the different bones and structures that make up the skull. The drawing is labeled with lines pointing to different parts of the skull, but the labels are illegible. The skull is set against a white background.
CRANIAL SOLUTIONS
602 Lincoln Avenue Pompton Lakes, N.J. 07442-1309 Tel: ( 973) 835-7929
510(k) Summary
June 12 2007 Kirk A Lucyk, CO Trade Name: Cranial Solutions Orthosis (CSO) Classification Name: Cranial Orthosis Classification # 882.5970 Code:MVA
The CSO is a custom made medical device intended to apply gentle pressure to prominent regions of the infant's cranium, and to provide realignment space for depressed cranial regions to improve symmetry and or shape. The device is of thermoplastic construct. A semi-rigid outer shell of Orthopedic grade copolymer polypropylene thermobonded to a medium durometer polyethylene foam inner liner(Volara). The formula for the outer shell is [ch(ch3)ch2-] 90% polypropylene and 10% polyethylene. By design the CSO is a dynamic orthotic device. As a predicate selection for substantial equivalence I would
like to reference the Dynamic Orthotic Cranioplasty (DOC) device and design.
The CSO and Cranial Technologies DOC device have the same indications for use: On infants three to eighteen months of age with moderate to severe non-synostotic positional plagiocephaly and other abnormal head shapes.
- Kirk A. Lucyk, C.O. - 602 Lincoln Avenue - Pompton Lakes, NJ 07442-1309 Email -eranialsol@gptonline.ne
1
Image /page/1/Picture/1 description: The image shows a side view of a human skull. The skull is drawn in black and white, with various bones and features labeled with lines. The skull appears to be a simplified anatomical illustration, possibly for educational purposes. The details of the skull, such as the eye socket, nasal cavity, and teeth, are visible.
CRANIAL SOLUTIONS
602 Lincoln Avenue Pompton Lakes, N.J. 07442-1309 Tel: ( 973) 835-7929
510(k) Summarv
Page 2
Both devices are Not intended for infant's with craniosynostosis or hydrocephalus. Both devices provide cranial orthotic treatment for infant's with nonsyndromic head deformity as a result of the utero process: e.g. compressional forces exerted by the lumbosacral spine, uterine malformation, fetal malpositioning, multiple fetuses oligohydramnios, and the current supine positioning recommendations. By design the CSO and DOC have a single lateral opening on the side adjacent to the flattened occipital-parieto region, provide a generous opening on top for air flow, and are very light in weight. Both devices can easily be adjusted for normal growth during the treatment process, and are easy to apply and remove by the care giver.
Both devices are of thermoplastic construction consisting of a semirigid outer shell bonded to a soft inner lining. Both outer shells are of Orthopedic grade plastic with hazard data all within OSHA permissible exposure limits with none know medical conditions aggravated by exposure. The CSO and DOC inner linings have been tested and approved by the FDA for long term skin contact. Both devices are of dynamic design , and when applied to an infant mild pressure, a low energy load , will constrain and correct abnormal growth . Normal growth will take place in the provided space and the cranial symmetry will be much improved.Standard treatment time for both cranial orthoses is three to four months.
- Kirk A. Lucyk, C.O. - 602 Lincoln Avenue - Pompton Lakes, NJ 07442-1309 Email -cranialsol@optonline.nel
2
K063133 pg 3 of 4
Image /page/2/Picture/1 description: This image shows a side view of a human skull. The skull is drawn in black and white, with various lines and shapes indicating the different bones and features of the skull. The skull is facing to the right, and the details of the eye socket, nasal cavity, and jaw are visible. The image appears to be a diagram or illustration, possibly from an anatomy textbook or educational resource.
CRANIAL SOLUTIONS
602 Lincoln Avenue Pompton Lakes, N.J. 07442-1309 Tel: ( 973) 835-7929
510(k) Summarv
page 3
By design specifications and design intent the CSO is vacuum formed over a modified cranial model obtained from a plaster cast taken of the infant's calvarium . Both the cranial solutions orthosis and the predicate device are formed only after the cranial model has been corrected or restored to as near as complete symmetry as possible. This exact correction will produce a very accurate and effective fit.
In keeping with our goal: To provide the safest, effective, and most comfortable cranial orthosis on an individual, custom, and prescription basis we at Cranial Solutions employ an important clinical tool. Our CSO Anthropometric measurement form. After obtaining the plaster impression we complete this form and explain it to parent or care giver. By encouraging the parents to be involved in the measurements(progress) they will keep and understand the need for biweekly follow-up appointments. By having the cranial orthosis and head circumference evaluated and recorded at preset intervals by the practitioner the risk factors can be reduced and the infant will have a much improved clinical outcome with their cranial orthosis.
- Kirk A. Lucyk C.O. - 602 Lincoln Avenue - Pompton Lakes, NJ 07442-1309 Email -cranialsol@optonline.net
3
CRANIAL SOLUTIONS
602 Lincoln Avenue Pompton Lakes, NJ 07442 (973) 835-7929
CRANIAL SOLUTIONS ORTHOSIS
The use of this device (CSO) is restricted to prescription use only by order of a Physician.
INTENDED USE: The CSO is intended for use on infants from three to eighteen months of age with moderate to severe non-synostotic positional plagiocephaly , including infants with plagiocephalic, brachycephalic, and scaphocephalic shaped heads. The CSO is intended to apply gentle pressure to prominent regions of the infants's cranium, and to provide realignment space for depressed cranial regions to improve cranial symmetry and or shape.
CONTRAINDICATIONS: The Cranial Solutions Orthosis (CSO) is contraindicated for infant's who have synostosis or hydrocephalus.
WARNINGS: All infants being treated with a cranial orthosis need to have their head circumference evaluated, measured, and recorded at preset intervals by a practitioner. eirounforous ovaluation and rate of head growth must be evaluated at age appropriate intervals to reduce the risk of restricting normal cranial growth and brain development. Into rate givers need to examine, evaluate, and monitor the infant's skin every r urone of our grover if skin irritation or breakdown occurs the orthosis must be removed and the practitioner must be called or consulted. Parents please remember that proper adherence to the care and usage instructions is necessary to reduce potential autherdrious to the barrywth, brain development, and your child's safety and comfort.
PRECAUTIONS: Parents or care giver be advised that if your child has torticollis it should also be treated additionally with the positional plagiocephaly. When receiving cranial orthotic treatment your child's device must be evaluated for fit and function on a preset and regular basis to avoid skin irritation, growth impairment, and assure normal brain development. It is also important to have your device checked or evaluated by your practitioner for structural integrity to reduce the potential to migrate out of place and cause asphyxiation, eye trauma, skin breakdown or prolonged discomfort.
ADVERSE EVENTS: Although your devices soft lining has been tested for long term direct skin contact; skin Irritation can occur when using this device. However most skin irritation can be avoided by strictly following the cleaning, drying, and care and usage instructions.Remember, check your child's skin every 3 to 4 hours.The Orthosis should fit snug, apply gentle pressure, and NOT be overly tight. Please follow the instructions that were provided with your child's CSO device.
4
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized eagle with three stripes extending from its back, representing the department's commitment to health, human services, and well-being. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle symbol.
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUL - 2 2007
Cranial Solutions % Kirk A. Lucyk, C.O. 602 Lincoln Ave. Pompton Lakes, New Jersey 07442-1309
Re: K063133/S2
Trade/Device Name: Cranial Solutions Orthosis (CSO) Regulation Number: 21 CFR 882.5970 Regulation Name: Cranial orthosis Regulatory Class: II Product Code: MVA Dated: May 9, 2007 Received: May 14, 2007
Dear Dr. Lucyk:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
5
Page 2 - Mr. Kirk A. Lucyk, C.O.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at toll-free number (800) 638-2041 or (240) 276-3150 or the Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours Mark N. Melkerson
Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
6
Indications for Use
510(k) Number (if known): K063133
Device Name: CRANIAL SOLUTIONS ORTHOSIS (CSO)
Indications For Use:
The Cranial Solutions Orthosis is intended for use on infants from three to eighteen months of age with moderate to severe non-synostotic positional plagiocephaly,including infants with plagiocephalic, brachycephalic, and scaphocephalic shaped heads. The CSO is intended to apply gentle pressure to prominent regions of the infant's cranium, and to provide realignment space for depressed cranial regions to improve cranial symmetry and or shape.
Prescription Use
(Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use _ (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
| (Division Sign-Off) | |
|---|---|
| Division of General, Restorative, and Neurological Devices 1 of | |
| 510(k) Number | 1663113 |